Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Parotitis,Mumps”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00975507
What this trial is testing

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 480
Not applicableStudy completedNCT00962819
What this trial is testing

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Who this might be right for
MeaslesMumpsRubella
Sri Edupuganti, MD MPH 74
Not applicableStudy completedNCT01390922
What this trial is testing

Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)

Who this might be right for
Mumps
GlaxoSmithKline 1,038
Large-scale testing (Phase 3)Study completedNCT00984295
What this trial is testing

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,913
Post-approval studies (Phase 4)Study completedNCT00126997
What this trial is testing

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline 1,439
Post-approval studies (Phase 4)Looking for participantsNCT05758532
What this trial is testing

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Who this might be right for
Respiratory Tract InfectionsInfectionsAllergy+1 more
Laure Pittet, MD-PhD 500
Large-scale testing (Phase 3)Study completedNCT00092430
What this trial is testing

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,200
Large-scale testing (Phase 3)Study completedNCT01702428
What this trial is testing

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Who this might be right for
RubellaMeaslesMumps
GlaxoSmithKline 5,016
Large-scale testing (Phase 3)Study completedNCT00985166
What this trial is testing

ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 801
Large-scale testing (Phase 3)Study completedNCT00192491
What this trial is testing

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Who this might be right for
Influenza
MedImmune LLC 1,200
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Not applicableStudy completedNCT02901990
What this trial is testing

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

Who this might be right for
Parotid Gland InfectionFever
Jiangsu Province Centers for Disease Control and Prevention 7,901
Post-approval studies (Phase 4)Study completedNCT00388440
What this trial is testing

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT00352898
What this trial is testing

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline 400
Large-scale testing (Phase 3)Study completedNCT00871117
What this trial is testing

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 478
Testing effectiveness (Phase 2)Ended earlyNCT00258726
What this trial is testing

Immune Responses to Two Dose Varivax +/- MMR-II

Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 105
Early research (Phase 1)Study completedNCT01712906
What this trial is testing

A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Who this might be right for
Mumps
Institute of Medical Biology, Chinese Academy of Medical Sciences 300
Not applicableLooking for participantsNCT05923970
What this trial is testing

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Who this might be right for
Vaccination FailureVaccine Response Impaired
University of Alberta 200
Large-scale testing (Phase 3)Looking for participantsNCT06855160
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 900
Load More Results